百济神州:身处癌症免疫治疗最前沿

Bei Gene: in the Forefront of Cancer Immunotherapy

＂我们希望最终创制出属于中国本土的具有全球竞争力的新药,让中国的肿瘤新药研发也可以与国际接轨,达到世界先进水平,进而改善国人的健康状况。＂

We hope to eventually create Chinese native globally competitive drug, let China tumor drug development can also be in line with international standards, reach the advanced world level, and improve the health of the people.